Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 257-261

  Chen, Yi Chyan ^a   Shen, Yu Chih ^b   Hung, Yi Jen ^a   Chao Ha, Chou ^a   Yeh, Chin Bin ^a   Perng, Cheng Hwang ^c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c ALETHEIA UNIVERSITY   (Taiwan)

Author keywords

Antidepressant; Depressive disorder; Glucose metabolism; Insulin sensitivity

Indexed keywords

FLUOXETINE; MAPROTILINE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE HOMEOSTASIS; HAMILTON SCALE; HOSPITALIZATION; HUMAN; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR DEPRESSION; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MAPROTILINE; PERSONALITY INVENTORY; SEROTONIN UPTAKE INHIBITORS;

EID: 34548836302     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.01.023     Document Type: Article

References (20)

1. Bambauer K.Z., Soumerai S.B., Adams A.S., Mah C., Zhang F., and McLaughlin T.J. Does antidepressant adherence have an effect on glycemic control among diabetic antidepressant users?. Int. J. Psychiatry Med. 34 (2004) 291-304
2. Bergman R.N., Phillips L.S., and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 68 (1981) 1456-1467
3. Berken G.H., Weinstein D.O., and Stern W.C. Weight gain. A side-effect of tricyclic antidepressants. J. Affect. Disord. 7 (1984) 133-138
4. Erenmemisoglu A., Ozdogan U.K., Saraymen R., and Tutus A. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J. Pharm. Pharmacol. 51 (1999) 741-743
5. Garland E.J., Remick R.A., and Zis A.P. Weight gain with antidepressants and lithium. J. Clin. Psychopharmacol. 8 (1988) 323-330
6. Ghaeli P., Shahsavand E., Mesbahi M., Kamkar M.Z., Sadeghi M., and Dashti-Khavidaki S. Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. J. Clin. Psychopharmacol. 24 (2004) 386-388
7. Gomez R., Huber J., Lhullier F., and Barros H.M. Plasma insulin levels are increased by sertraline in rats under oral glucose overload. Braz. J. Med. Biol. Res. 34 (2001) 1569-1572
8. Goodnick P.J., Kumar A., Henry J.H., Buki V.M., and Goldberg R.B. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol. Bull. 33 (1997) 261-264
9. Hung Y.J., Hsieh C.H., Pei D., Kuo S.W., Lee J.T., Wu L.Y., He C.T., Lee C.H., Fan S.C., and Sheu W.H. Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance. Clin. Endocrinol. (Oxf) 62 (2005) 85-91
10. Isotani H., and Kameoka K. Hypoglycemia associated with maprotiline in a patient with type 1 diabetes. Diabetes Care 22 (1999) 862-863
11. Kopf D., Westphal S., Luley C.W., Ritter S., Gilles M., Weber-Hamann B., Lederbogen F., Lehnert H., Henn F.A., Heuser I., and Deuschle M. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J. Clin. Psychopharmacol. 24 (2004) 527-531
12. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., Carney R.M., and McGill J.B. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med. 59 (1997) 241-250
13. Lustman P.J., Anderson R.J., Freedland K.E., de Groot M., Carney R.M., and Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 (2000) 934-942
14. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
16. McIntyre R.S., Soczynska J.K., Konarski J.Z., and Kennedy S.H. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin. Drug Saf. 5 (2006) 157-168
17. Okamura F., Tashiro A., Utsumi A., Imai T., Suchi T., and Hongo M. Insulin resistance in patients with depression and its changes in the clinical course of depression: a report on three cases using the minimal model analysis. Intern. Med. 38 (1999) 257-260
18. Sansone R.A., and Sansone L.A. Sertraline-induced hyperglycemia: case report. Int. J. Psychiatry Med. 33 (2003) 103-105
19. Yamada J., Sugimoto Y., and Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur. J. Pharmacol. 382 (1999) 211-215
20. Zimmermann U., Kraus T., Himmerich H., Schuld A., and Pollmacher T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J. Psychiatr. Res. 37 (2003) 193-220